DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$18.89
Tradestie Score
52
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+91.6%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.36
|
$3.40B | 97.3 | 53 | Compare |
|
QURE
uniQure N.V.
|
$24.63
|
$3.39B | - | 52 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$43.16
|
$3.33B | - | 52 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$19.97
|
$3.31B | - | 44 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$15.50
|
$3.09B | - | 55 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$27.58
|
$3.08B | - | 41 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$41.00
|
$3.02B | - | 25 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$70.15
|
$3.01B | - | 42 | Compare |
More DNLI Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry